CIK 0001527352 · <br>Emerging growth company
Nexalin Technology, Inc.
Sign in to watch- Ticker
- NXL
- Exchange
- Nasdaq
- Industry
- Electromedical & Electrotherapeutic Apparatus
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 275566468
- Phone
- (832) 260-0222
- Business address
- 1776 YORKTOWN, SUITE 550, HOUSTON, TX, 77056
- 4 Derivatives Options or other derivatives
- 8-K Event Shareholder vote results
- DEF 14A Proxy Proxy Statement
- 8-K Event Other events
- 10-Q Report Quarterly Report
- 8-K Event Material agreement · Other events
- 424B4 Offering Prospectus
- 424B5 Offering Prospectus
- 8-K Event Material agreement
- 424B4 Offering Prospectus
- EFFECT Other Notice of Effectiveness
- CORRESP Other Correspondence Between Filers and SEC Staff
- S-3 Offering Registration Statement
- 8-K Event Auditor change
- 10-K/A Report 10-K/A
- DRSLTR Other Correspondence Related to Draft Registration Statement
- UPLOAD Other SEC-generated Letter
- DRS Other Draft Registration Statement
- 10-K Report Annual Report
- 4 Open-market buy Sr. VP - Quality, Regulatory bought 6,000 shares at $2.20 ($13,200)
Page 4 of 11 · 206 filings